ARTICLE | Management Tracks
Kevin Oliver named CBO at Acadia
Plus: Editas hires Linda Burkly as CSO, and updates from Bicara, Senda, Aurobac and Velia
July 25, 2023 12:31 AM UTC
Neuroscience company Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) hired Kevin Oliver as SVP and CBO. Oliver, a 23-year veteran of Merck & Co. Inc. (NYSE:MRK), was most recently COO, U.S. and Europe, and SVP, head of global business development & licensing and alliance management at Simcere Pharmaceutical Group Ltd. (HKEX:2096).
Gene editing company Editas Medicine Inc. (NASDAQ:EDIT) hired Linda Burkly as EVP and CSO. Burkly held several roles at Biogen Inc. (NASDAQ:BIIB) over 37 years, including VP and senior distinguished investigator...